SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058657
Filing Date
2024-05-13
Accepted
2024-05-13 16:09:58
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20240331.htm   iXBRL 10-Q 1556445
2 EX-31.1 sprb-ex31_1.htm EX-31.1 15837
3 EX-31.2 sprb-ex31_2.htm EX-31.2 14779
4 EX-32.1 sprb-ex32_1.htm EX-32.1 7814
5 EX-32.2 sprb-ex32_2.htm EX-32.2 7927
  Complete submission text file 0000950170-24-058657.txt   5200306

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20240331.xsd EX-101.SCH 856485
55 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20240331_htm.xml XML 518609
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 24939116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)